Skip to main content

clinical trial Archives

Clinical trial at VUMC tests novel treatment for asthma

Nov. 10, 2022—VUMC has begun enrolling patients with asthma in a clinical trial of a novel treatment: a medication approved to treat diabetes and obesity.

Read more


Study finds that reducing intake of simple sugars improves GERD

Oct. 6, 2022—A Vanderbilt study found that reducing dietary carbohydrates improved both symptoms and objective measurements of gastroesophageal reflux disease (GERD) in a randomized controlled trial.

Read more


VUMC study will evaluate alternative strategies for administering monkeypox vaccine

Sep. 7, 2022—Vanderbilt is seeking about 30 healthy adults of diverse backgrounds to participate in a national clinical trial to evaluate alternative strategies for administering the monkeypox vaccine

Read more


Study shows life-saving benefit of baricitinib for ventilated COVID patients

Feb. 7, 2022—Vanderbilt research shows that critically ill COVID-19 patients on a mechanical ventilator or extracorporeal membrane oxygenation lived more often when randomized to receive baricitinib.

Read more


Volunteers needed for study of nuts, abdominal fat and metabolic risk

Jan. 3, 2022—Help researchers learn more about how consuming nuts affects body weight, waist circumference and abdominal fat. Researchers at Vanderbilt University Medical Center are looking for volunteers for a study that will compare a diet with mixed nuts as snacks to a diet with typical snacks to determine the effects on abdominal fat and risk for...

Read more


International study supports dupilumab for treatment of moderate-to-severe asthma in children

Dec. 8, 2021—In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11 with moderate-to-severe asthma, offering a new option to these patients.

Read more


Mothers with depression needed for research study

Nov. 19, 2021—Are you a mother who has been feeling stressed, sad, or down? Researchers at Vanderbilt University are recruiting 8-to 12-year-old children and their biological mothers for a study of depression prevention. Mothers and their children will be asked to complete questionnaires, fill out cell phone surveys for 10 days and complete an 8-week virtual intervention....

Read more


Teens with depression study needs participants

Nov. 19, 2021—Volunteers are needed for a research study to better understand depression in teens aged 14-17 years. Teens and their biological mothers can earn up to $140 combined. If you are interested in learning more, complete the contact form here: https://redcap.link/teenstudies and a study team member will be in touch within 2-5 business days. For more information, call...

Read more


Shifts in neuroendocrine cancer clinical trial design

Nov. 2, 2021—Clinical trials that focus on specific types of neuroendocrine neoplasms — heterogeneous tumors that can occur anywhere in the body — will be more likely to enhance drug development for these tumors, Vanderbilt physicians assert.

Read more


Facebook campaign quickly nets clinical trial participants

Aug. 5, 2021—The cost and effectiveness of social media as a participant recruitment tool for clinical research is still being evaluated. To better understand its utility, researchers at Vanderbilt University Medical Center used Facebook to mount a short, monthlong pilot campaign in and around Houston attempting to recruit participants for an ongoing smoking cessation study being conducted in that city.

Read more


VUMC is pacesetter for national aspirin study

May. 20, 2021—According to an innovative large-scale clinical trial reported last week in the New England Journal of Medicine, a single daily baby aspirin (81 mg) or a single daily adult aspirin (325 mg) are equally safe and effective for prevention of adverse cardiovascular events for patients with established atherosclerotic cardiovascular disease.

Read more


Monroe Carell Jr. Children’s Hospital at Vanderbilt selected as trial site for pediatric COVID-19 vaccine

Mar. 30, 2021—Monroe Carell Jr. Children’s Hospital at Vanderbilt is set to begin a phase 2/3 clinical trial to study the safety and efficacy of the Moderna COVID-19 vaccine in children.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more